Atlas Trials

The Role of Neutrophil CD64 and Soluble Triggering Receptor Expressed on Myeloid Cells 1 in Neonatal Sepsis

Clinical trial NCT03795285 · UNKNOWN

Trial details

NCT number
NCT03795285
Sponsor
Assiut University
Status
UNKNOWN
Study type
OBSERVATIONAL
Neonatal SEPSIS
Start date
2019-02-20
Primary completion
2019-09-20
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.